{"entity":{"type":"insider","cik":"0001638989","url":"/insider/0001638989","json_url":"/insider/0001638989.json","name":"Bourdow Carrie L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2016-11-10","last":"2022-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Bourdow Carrie L.","source":"filing","n_filings":4,"first_seen":"2016-11-10","last_seen":"2022-08-03"}],"transactions":[{"id":6366134,"accession":"0001104659-22-085789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-085789","line_url":"/filing/0001104659-22-085789#line-1","is_derivative":false,"issuer_cik":"0001638989","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001638989","owner_cik":"0001638989","owner_name":"Bourdow Carrie L.","owner_display_name":"Bourdow Carrie L.","owner_url":"/insider/0001638989","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8540.0,"shares_display":"8,540","price_per_share":0.1741,"price_display":"0.17","price_state":"stated","total_value":1486.814,"total_display":"1,486.81","total_whole":"1,487","shares_owned_after":9933.0,"shares_owned_after_display":"9,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":4211247,"accession":"0001104659-21-100287","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-100287","line_url":"/filing/0001104659-21-100287#line-1","is_derivative":false,"issuer_cik":"0001638989","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001638989","owner_cik":"0001638989","owner_name":"Bourdow Carrie L.","owner_display_name":"Bourdow Carrie L.","owner_url":"/insider/0001638989","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":777.0,"shares_display":"777","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":932.4,"total_display":"932.40","total_whole":"932","shares_owned_after":18473.0,"shares_owned_after_display":"18,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":4551838,"accession":"0001192482-21-000576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-21-000576","line_url":"/filing/0001192482-21-000576#line-1","is_derivative":false,"issuer_cik":"0001429560","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001429560","owner_cik":"0001638989","owner_name":"Bourdow Carrie L.","owner_display_name":"Bourdow Carrie L.","owner_url":"/insider/0001638989","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56200.0,"shares_display":"56,200","price_per_share":1.789,"price_display":"1.79","price_state":"stated","total_value":100541.8,"total_display":"100,541.80","total_whole":"100,542","shares_owned_after":1301510.0,"shares_owned_after_display":"1,301,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-28","scope":"insider"},{"id":2517420,"accession":"0001209191-16-149452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-149452","line_url":"/filing/0001209191-16-149452#line-1","is_derivative":false,"issuer_cik":"0001429560","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001429560","owner_cik":"0001638989","owner_name":"Bourdow Carrie L.","owner_display_name":"Bourdow Carrie L.","owner_url":"/insider/0001638989","role":"Officer (SVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":4.34,"price_display":"4.34","price_state":"stated","total_value":17360.0,"total_display":"17,360.00","total_whole":"17,360","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641640","name":"Nabriva Therapeutics plc","url":"/issuer/0001641640","role":"Director","n_filings":2,"first_seen":"2021-08-04","last_seen":"2022-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001429560","name":"TREVENA INC","url":"/issuer/0001429560","role":"Director, Officer (President & CEO)","n_filings":2,"first_seen":"2016-11-10","last_seen":"2021-06-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001638989","retrieved_at":"2026-08-23T09:07:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}